AT511187A5 - Polypeptidmaterial aus elastin-ähnlichen Segmenten und Coiled-Coil Segmenten - Google Patents

Polypeptidmaterial aus elastin-ähnlichen Segmenten und Coiled-Coil Segmenten Download PDF

Info

Publication number
AT511187A5
AT511187A5 ATA9495/2009A AT94952009A AT511187A5 AT 511187 A5 AT511187 A5 AT 511187A5 AT 94952009 A AT94952009 A AT 94952009A AT 511187 A5 AT511187 A5 AT 511187A5
Authority
AT
Austria
Prior art keywords
segments
elastin
polypeptide material
coiled
cells
Prior art date
Application number
ATA9495/2009A
Other languages
English (en)
Other versions
AT511187A2 (de
Original Assignee
Kemijski Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemijski Inst filed Critical Kemijski Inst
Publication of AT511187A2 publication Critical patent/AT511187A2/de
Publication of AT511187A5 publication Critical patent/AT511187A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die Erfindung stellt Polypeptidmaterial, zusammengesetzt aus mindestens einem Elastin-ähnlichen Segment und mindestens zwei Segmenten zur Bildung von Doppelwendeln dar, und optional noch einer funktionellen Polypeptiddomäne. Die Elastinähnlichen Segmente aber stellen mindestens vier für Elastin typische Wiederholungen dar. Die Erfindung bezieht sich auf die Anwendung von Polypeptidmaterial zur Wachstumsbeschleunigung von Zellen, Gewebe und Organen, zur Differenzierung von Zellen, der Wachstumshemmung von Pathogenen, zur Behandlung von lebendem menschlichen oder tierischen Gewebe und als medizinisches und pharmazeutisches Material, das zur Behandlung von Lebendgewebe von Nutzen sein wird
ATA9495/2009A 2009-10-12 2009-10-12 Polypeptidmaterial aus elastin-ähnlichen Segmenten und Coiled-Coil Segmenten AT511187A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SI2009/000047 WO2011046519A1 (en) 2009-10-12 2009-10-12 Polypeptide material composed of elastin-like segments and coiled coil segments

Publications (2)

Publication Number Publication Date
AT511187A2 AT511187A2 (de) 2012-09-15
AT511187A5 true AT511187A5 (de) 2015-02-15

Family

ID=42166455

Family Applications (1)

Application Number Title Priority Date Filing Date
ATA9495/2009A AT511187A5 (de) 2009-10-12 2009-10-12 Polypeptidmaterial aus elastin-ähnlichen Segmenten und Coiled-Coil Segmenten

Country Status (2)

Country Link
AT (1) AT511187A5 (de)
WO (1) WO2011046519A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102360497B (zh) * 2011-10-19 2013-06-12 西安电子科技大学 基于并行免疫克隆聚类的sar图像分割方法
US9332010B2 (en) 2014-03-07 2016-05-03 Motorola Solutions, Inc. Methods and systems for token-based application management
LU501018B1 (en) * 2021-12-15 2023-06-15 Kemijski Institut Nat Institute Of Chemistry Regulation of protein function by insertion of interaction peptides
WO2023161219A2 (en) * 2022-02-23 2023-08-31 Oslo Universitetssykehus Hf Tuned car
CN117777245B (zh) * 2023-06-13 2024-06-07 红河学院 一种虫草素-抗菌肽偶合物及其合成方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090170959A1 (en) * 2007-06-18 2009-07-02 Jin Kim Montclare Polymer carrier

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219451A1 (en) * 2001-10-29 2003-11-27 Whitehead Institute For Biomedical Research Stable helical C peptides and uses therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090170959A1 (en) * 2007-06-18 2009-07-02 Jin Kim Montclare Polymer carrier

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Diehl MR, Zhang K, Lee HJ, Tirrell DA. Engineering cooperativity in biomotor-protein assemblies. Science. 2006 Mar 10;311(5766):1468-71. *
Petka WA, Harden JL, McGrath KP, Wirtz D, Tirrell DA. Reversible hydrogels from self-assembling artificial proteins. Science. 1998 Jul 17;281(5375):389-92. *

Also Published As

Publication number Publication date
WO2011046519A1 (en) 2011-04-21
AT511187A2 (de) 2012-09-15

Similar Documents

Publication Publication Date Title
EA201101243A1 (ru) 3h-имидазо[4,5-c]пиридин-6-карбоксамиды в качестве противовоспалительных средств
HRP20190031T1 (hr) Sintetski triterpenoidi i postupci njihove upotrebe u liječenju bolesti
EP2415476A4 (de) Zusammensetzung zur vorbeugung und/oder behandlung von hautkrankheiten
EP2415763A4 (de) Pharmazeutische zusammensetzungen zur behandlung oder prävention von glaukom
EP2194888A4 (de) Behandlung von dysfunktionalem herzgewebe
CL2014000833A1 (es) Composicion para ser usada en la promocion del crecimiento de hueso sano y/o en la prevencion y/o tratamiento de la enfermedad osea
DOP2012000299A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
SV2011004019A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
MX2015002289A (es) Anticuerpos humanos para gfr alfa 3 y métodos para su uso.
EP2898064A4 (de) Zusammensetzungen und verfahren zur behandlung und prävention von gewebeverletzungen und -krankheiten
RU2008100042A (ru) Новое производное кислоты тритерпенового ряда и содержащий его препарат для наружного применения для кожи
EP1991274A4 (de) Verfahren zur behandlung, prophylaxe und diagnose von knochenerkrankungen
WO2005079822A3 (en) Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds
EA201170190A1 (ru) Фармацевтическая композиция, содержащая экстракт мозга свиньи
GB0919031D0 (en) Apparatus and methods for the treatment of human or animal tissue by light
EP4297765A4 (de) Zusammensetzung zur behandlung von topischen dermatologischen bakteriellen hauterkrankungen
FR2992173B1 (fr) Procece cosmetique d'eclaircissement de la peau et/ou des levres
FR2994386B1 (fr) Inhibition de l'adhesion de micro-organismes pathogenes par un ester de saccharose et/ou de sorbitan dans le traitement cosmetique de l'atopie cutanee
FR2954837B1 (fr) Procede d'evaluation de l'etat esthetique et morphologique de la peau et prescription d'un traitement cosmetique et/ou dermatologique
WO2010094734A3 (en) Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
EP3669880A4 (de) Verwendung von mir-18b zur vorbeugung, behandlung oder diagnose von muskelerkrankungen und neuromuskulären erkrankungen
EP2289575A3 (de) Medizinisches Implantat enthaltend eine antioxidative Substanz
DE112010001393A5 (de) Pflanzen-extrakte zur behandlung von hauterkrankungen

Legal Events

Date Code Title Description
REJ Rejection

Effective date: 20240615